title: Case of anti-RuvBL1/2 antibody-positive morphea and polymyositis.
authors: Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.
authors: Toshifumi
authors: T
authors: Takahashi
authors: Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.
authors: Takeshi
authors: T
authors: Nakanishi
authors: Department of Dermatology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
authors: Yasuhito
authors: Y
authors: Hamaguchi
authors: Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.
authors: Toshihiro
authors: T
authors: Tanaka
authors: Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.
authors: Noriki
authors: N
authors: Fujimoto
mesh_terms: D000074183:ATPases Associated with Diverse Cellular Activities / Q000276:immunology*; D000328:Adult; D001323:Autoantibodies / Q000097:blood / Q000276:immunology*; D001379:Azathioprine / Q000627:therapeutic use; D002352:Carrier Proteins / Q000276:immunology*; D004265:DNA Helicases / Q000276:immunology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017285:Polymyositis / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D012594:Scleroderma, Localized / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D011239:Prednisolone; D000074183:ATPases Associated with Diverse Cellular Activities; D004265:DNA Helicases; C486549:RUVBL1 protein, human; C122079:RUVBL2 protein, human; D001379:Azathioprine